| Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation JC Rodríguez-Prados, PG Través, J Cuenca, D Rico, J Aragonés, ... The Journal of Immunology 185 (1), 605-614, 2010 | 1151 | 2010 |
| Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1/2 randomized controlled trial (RIMECARD trial … J Bartolucci, FJ Verdugo, PL González, RE Larrea, E Abarzua, C Goset, ... Circulation research 121 (10), 1192-1204, 2017 | 443 | 2017 |
| Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies F Alcayaga-Miranda, J Cuenca, M Khoury Frontiers in immunology 8, 339, 2017 | 302 | 2017 |
| Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 M Khoury, J Cuenca, FF Cruz, FE Figueroa, PRM Rocco, DJ Weiss European respiratory journal 55 (6), 2020 | 257 | 2020 |
| Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells F Alcayaga-Miranda, J Cuenca, P Luz-Crawford, C Aguila-Díaz, ... Stem cell research & therapy 6, 1-14, 2015 | 167 | 2015 |
| Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis F Alcayaga-Miranda, J Cuenca, A Martin, L Contreras, FE Figueroa, ... Stem cell research & therapy 6, 1-13, 2015 | 166 | 2015 |
| Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways P Prieto, J Cuenca, PG Través, M Fernández-Velasco, P Martín-Sanz, ... Cell Death & Differentiation 17 (7), 1179-1188, 2010 | 133 | 2010 |
| Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma L Rosenberger, M Ezquer, F Lillo-Vera, PL Pedraza, MI Ortúzar, ... Scientific reports 9 (1), 663, 2019 | 126 | 2019 |
| Tumour necrosis factor‐α (TNF‐α) levels and influence of− 308 TNF‐α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis M Cuchacovich, L Ferreira, M Aliste, L Soto, J Cuenca, A Cruzat, H Gatica, ... Scandinavian journal of rheumatology 33 (4), 228-232, 2004 | 108 | 2004 |
| Chorion mesenchymal stem cells show superior differentiation, immunosuppressive, and angiogenic potentials in comparison with haploidentical maternal placental cells PL González, C Carvajal, J Cuenca, F Alcayaga-Miranda, FE Figueroa, ... Stem cells translational medicine 4 (10), 1109-1121, 2015 | 96 | 2015 |
| Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors T Castaño, H Wang, NE Campillo, S Ballester, C González‐García, ... ChemMedChem: Chemistry Enabling Drug Discovery 4 (5), 866-876, 2009 | 83 | 2009 |
| Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to … J Cuenca, CA Pérez, AJ Aguirre, I Schiattino, JC Aguillón Biological Research 34 (3-4), 237-241, 2001 | 80 | 2001 |
| The− 308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide‐induced TNF expression and cytotoxic activity in Chilean patients … J Cuenca, M Cuchacovich, C Perez, L Ferreira, A Aguirre, I Schiattino, ... Rheumatology 42 (2), 308-313, 2003 | 76 | 2003 |
| Exosomes on the border of species and kingdom intercommunication CMAP Schuh, J Cuenca, F Alcayaga-Miranda, M Khoury Translational Research 210, 80-98, 2019 | 50 | 2019 |
| The–308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-α) gene and ex vivo lipopolysaccharide-induced TNF-α expression in patients with aggressive … C Pérez, FE González, V Pavez, AV Araya, A Aguirre, A Cruzat, ... European Cytokine Network 15 (4), 364-370, 2004 | 46 | 2004 |
| The reparative abilities of menstrual stem cells modulate the wound matrix signals and improve cutaneous regeneration J Cuenca, A Le-Gatt, V Castillo, J Belletti, M Díaz, M Kurte G, PL Gonzalez, ... Frontiers in physiology 9, 464, 2018 | 45 | 2018 |
| Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis J Cuenca, P Martín-Sanz, AM Álvarez-Barrientos, L Boscá, N Goren The American journal of pathology 169 (5), 1567-1576, 2006 | 42 | 2006 |
| Attenuation of NF-κB signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes N Goren, J Cuenca, P Martín-Sanz, L Boscá Cardiovascular research 64 (2), 289-297, 2004 | 40 | 2004 |
| MicroRNA profiling of B cell subsets from systemic lupus erythematosus patients reveals promising novel biomarkers I Duroux-Richard, J Cuenca, C Ponsolles, A Badilla Piñeiro, F Gonzalez, ... International Journal of Molecular Sciences 16 (8), 16953-16965, 2015 | 37 | 2015 |
| El polimorfismo genético del factor de necrosis tumoral alfa como factor de riesgo en patología JC Aguillón, A Cruzat, J Cuenca, M Cuchacovich Revista médica de Chile 130 (9), 1043-1050, 2002 | 29 | 2002 |
